Filing Impact
Filing Sentiment
Form Type
4
Omeros
Jul 25, 2025
[8-K] Omeros Corporation Reports Material Event
Jul 2, 2025
[8-K] Omeros Corporation Reports Material Event
283.11M
65.48M
3.79%
42.69%
19.04%
Biotechnology
Pharmaceutical Preparations
United States
SEATTLE